Comparing the current results to its competitors, Perrigo Plc reported Revenue decrease in the 1 quarter 2026 year on year by -7.17 %, despite the revenue increase by the most of its competitors of 6.19 %, recorded in the same quarter.
Perrigo Company Plc, slower than the average decrease reported by the company's competitors of -15.38 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -15.38 %
Perrigo Plc's Comment on Competition and Industry Peers
The competitive landscape includes other industry participants, some of which have greater marketing resources or larger market shares in specific product categories. Additional challenges include pricing pressures from customers and consumers.
Abbott Laboratories operates as a diversified healthcare company with a focus on developing and manufacturing a wide range of health-related products, including pharmaceuticals, medical devices, nutritional products, and diagnostic technologies. Their business model emphasizes innovation and quality, aiming to address the diverse needs of patients and healthcare providers across various sectors globally. By leveraging their expertise and extensive portfolio, Abbott strives to enhance patient outcomes and improve the overall quality of life.
Aim Immunotech Inc is a biopharmaceutical company that focuses on the development of therapeutics for various immune-related disorders. Their business model revolves around the research and development of novel drugs using their proprietary platforms. They aim to advance innovative treatments by collaborating with partners and leveraging their expertise in the field of immunotherapy.
Amneal Pharmaceuticals Inc operates as a fully integrated pharmaceutical company, primarily focused on the development, manufacturing, and distribution of generic and specialty pharmaceutical products. Their business model revolves around identifying market opportunities, conducting research to develop cost-effective formulations, and leveraging their expansive manufacturing capabilities to produce and distribute a wide range of pharmaceuticals to customers globally. Additionally, they aim to provide high-quality products at competitive prices while continuously investing in research and development to expand their product portfolio.
AptarGroup Inc is a global provider of packaging solutions, specializing in dispensing systems and closures for a wide range of industries. Their business model revolves around designing and manufacturing innovative packaging solutions that enhance product functionality and consumer experience, catering to the needs of various market sectors.
Bristol Myers Squibb Company operates a research and development-driven business model, focusing on the discovery and delivery of innovative medicines for various diseases. It emphasizes collaboration with academic institutions, government entities, and other pharmaceutical firms to enhance its therapeutic portfolio and improve patient outcomes.
Sources:
Perrigo Company Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Perrigo Company Plc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
